Module 2 views communication with the FDA as a core regulatory strategy, where clarity in framing issues and requests directly impacts the efficiency and outcome of interactions. We will focus on structuring clear written and verbal communication, preparing for meetings, and advocating constructively to create a well-supported path toward regulatory alignment.

This module reframes these interactions not as conversations, but as high-stakes, formal decision events that dictate your product's regulatory trajectory. It emphasizes that because these interactions are often a "one-shot" reality, successful preparation must focus on achieving internal alignment, designing conditional questions that the FDA can answer, and controlling risk in a constrained environment.

Module 4 addresses managing the high-stakes negotiation of an FDA inspection in the medical device industry. It focuses on how the new Quality System Management Regulation (QMSR) and the Office of Inspections and Investigations (OII) have fundamentally changed the rules of engagement. We will learn to manage the inspection narrative, emphasizing disciplined communication.

Module 5 explores three high-stakes areas of FDA communication and negotiation: dispute resolution, regulatory crisis management, and preparation for FDA Advisory Committee meetings. The module details both formal and informal pathways for breaking impasses, strategies for managing crises with transparency and accountability, and the rigorous planning required for a successful public expert review.